Ziresovir significantly improved clinical outcomes and reduced RSV viral load in infants compared to placebo in a phase 3 trial. The trial involved infants aged 1 to 24 months, with ziresovir showing ...

After a 2022–2023 season marked by a severe epidemic of bronchiolitis due to respiratory syncytial virus (RSV), in particular in terms of emergency department visits and hospital admissions, on ...

Bronchiolitis often affects infants under 2 and is usually caused by the respiratory syncytial virus (RSV). Bronchitis can happen at any age and involves inflammation due to viral infections like ...

Nirsevimab implementation in Catalonia, Spain, was associated with a 44% reduction in emergency department (ED) visits for bronchiolitis in infants younger than 6 months and a 48% reduction in ...

Placing a baby on their stomach in the prone position can help them breathe more comfortably. With the chest facing down and the back facing up, this position takes pressure off the lungs, allowing ...

RSV testing among infants has increased since 2015, with significant growth post-COVID-19, yet outpatient testing remains low. The study analyzed 20,752 bronchiolitis encounters across four healthcare ...

Immunisation with nirsevimab reduced bronchiolitis-related hospitalisations among infants younger than 3 months who visited the emergency department (ED), according to a new study. Nirsevimab also ...

Please provide your email address to receive an email when new articles are posted on . Researchers found elevated odds for severe bronchiolitis hospitalization in infants with household cleaning ...

The NHS warns parents about winter illnesses affecting babies, with a new flu variant and bronchiolitis causing hospital pressures in the UK. The NHS urges parents to keep a close eye on their babies’ ...